Oramed Pharmaceuticals In... (ORMP)

AI Score

Unlock

2.18

-0.02 (-0.91%)

At close: Apr 03, 2025, 3:59 PM

2.17

-0.57%

After-hours: Apr 03, 2025, 07:53 PM EDT

Oramed Pharmaceuticals Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Dec 31, 2023	Dec 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019	Aug 31, 2018	Aug 31, 2017	Aug 31, 2016	Aug 31, 2015	Aug 31, 2014	Aug 31, 2013	Aug 31, 2012	Aug 31, 2011	Aug 31, 2010	Aug 31, 2009	Aug 31, 2008	Aug 31, 2007	Aug 31, 2006	Aug 31, 2005	Aug 31, 2004	Aug 31, 2003
Revenue	1.34M	2.7M	2.7M	2.71M	2.7M	2.45M	2.46M	641K	n/a	n/a	n/a	184.25K	197.41K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	90K	90K	86K	187K	490K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	1.34M	2.7M	2.7M	2.62M	2.61M	2.36M	2.27M	151K	n/a	n/a	n/a	184.25K	197.41K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-15.77M	-40.6M	-24.22M	-11.76M	-14.63M	-13.53M	-10.77M	-10.01M	-7.38M	-5.91M	-4.3M	2.88M	-2.44M	-2.97M	-2.78M	-2.68M	-3.13M	-412.88K	-44.81K	-720K	-50K
Interest Income	8.03M	3.57M	347K	690K	1.06M	903K	785K	474K	168K	225K	18.73K	13.13K	33.23K	24.69K	38.6K	-83.19K	-11K	1.99K	n/a	n/a	n/a
Pretax Income	5.09M	-37.66M	-22.99M	-11.51M	-14.05M	-12.73M	-10.08M	-9.63M	-7.23M	-5.69M	-4.44M	-3.25M	-1.59M	-2.96M	-2.76M	2.61M	-3.24M	-414.58K	-45.78K	-720K	-50K
Net Income	5.53M	-37.76M	-22.24M	-11.51M	-14.36M	-12.73M	-10.48M	-10.96M	-7.23M	-5.7M	-4.23M	-3.34M	-1.56M	-2.98M	-2.76M	-2.77M	-3.24M	-414.58K	-45.78K	-720K	-50K
Selling & General & Admin	8.14M	15.66M	5.94M	4.23M	3.72M	4.08M	2.76M	2.45M	2.6M	2.63M	2.03M	1.2M	1.28M	1.51M	1.26M	1.5M	918K	215.13K	44.81K	280K	50K
Research & Development	8.97M	27.64M	20.99M	10.23M	13.52M	11.98M	10.28M	7.71M	4.78M	3.28M	2.27M	1.68M	1.16M	1.46M	1.52M	1.18M	2.21M	197.75K	n/a	n/a	10K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	440K	-10K
Operating Expenses	17.11M	43.3M	26.93M	14.47M	17.24M	16.06M	13.04M	10.16M	7.38M	5.91M	4.3M	2.88M	2.44M	2.97M	2.78M	2.68M	3.13M	412.88K	44.81K	720K	50K
Interest Expense	3.58M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	11K	313.45K	199.12K	18.78K	14.54K	17.55K	10.28K	-3.24M	3.68K	-44.81K	n/a	n/a
Selling & Marketing Expenses	-287K	1.85M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	17.11M	43.3M	26.93M	14.47M	17.33M	15.98M	13.23M	10.65M	7.38M	5.91M	4.3M	2.88M	2.44M	2.97M	2.78M	2.68M	3.13M	412.88K	44.81K	720K	50K
Income Tax Expense	n/a	100K	-2.88M	192K	300K	-800K	400K	1.33M	-1K	4K	-205.06K	90.22K	-23.98K	14.97K	-2.6K	162.16K	3.24M	414.58K	45.78K	n/a	n/a
Shares Outstanding (Basic)	40.32M	39M	28.47M	20.53M	17.45M	14.88M	13.31M	12.62M	10.82M	9.24M	7.21M	5.88M	5.42M	4.78M	4.72M	4.05M	3.52M	2.78M	1.54M	2.54M	2.9M
Shares Outstanding (Diluted)	40.57M	39M	28.47M	20.53M	17.45M	14.88M	13.31M	12.62M	10.82M	9.24M	7.21M	5.88M	5.42M	4.78M	4.72M	4.05M	3.52M	2.78M	1.54M	2.54M	2.9M
EPS (Basic)	0.14	-0.97	-0.78	-0.56	-0.82	-0.86	-0.79	-0.87	-0.67	-0.62	-0.59	-0.57	-0.29	-0.62	-0.58	-0.68	-0.92	-0.15	-0.03	-0.28	-0.02
EPS (Diluted)	0.14	-0.97	-0.78	-0.56	-0.82	-0.86	-0.79	-0.87	-0.67	-0.62	-0.59	-0.57	-0.29	-0.62	-0.58	-0.68	-0.92	-0.15	-0.03	-0.28	-0.02
EBITDA	-15.57M	-36.98M	-25.04M	-11.31M	-14.17M	-13.49M	-10.76M	-9.99M	-7.38M	-5.67M	-4.13M	-2.86M	-2.37M	-2.92M	-2.72M	-2.66M	-3.02M	-412.88K	-44.81K	-720K	-50K
EBIT	7.13M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	196K	3.62M	77K	7K	8K	6K	5K	4K	4K	6K	5.38K	14.74K	28.3K	31.86K	30.49K	15.45K	108K	-1.69K	-973	n/a	n/a